A CRT-D is a special device for heart failure patients who are also at high risk for sudden cardiac death. While functioning like a normal pacemaker to treat slow heart rhythms, a CRT-D device also delivers small electrical impulses to the left and right ventricles to help them contract at the same time. This will help your heart pump more efficiently. A CRT-D device can also treat dangerously fast heart rhythms (arrhythmias) that can lead to sudden cardiac arrest. If the device senses heartbeats that are dangerously fast, it delivers a shock to the heart. This shock (defibrillation) stops the abnormal rhythm. Without this life-saving therapy, the dangerously rapid rhythm could lead to death in just minutes. Factors such as rising incidences of cardiac disorders, advanced surgical procedures such as minimally invasive (MI) surgeries, patient awareness, and increasing healthcare spending are the primary growth drivers for the CRT-D market. Several clinical research studies indicate that when compared to CRT-P devices, the CRT-D devices can reduce re-admissions to the hospital for patients with heart failure, which is leading to their increased implementation in several cardiac procedures. Also, CRT-D devices lower the risk of sudden cardiac death (SCD) and improve the left ventricular function. The Americas will be the largest revenue contributing region in the market by 2020 and is expected to occupy more than 55% of the total market share. The rising incidences of cardiac disorders and growing awareness about cardiac diseases are the primary growth drivers for this region. Factors such as growing number of implant centers, technological advancements and easy availability of reimbursements will propel the sales of CRT-D devices in the region. In 2019, the market size of Cardiac Resynchronization Therapy Defibrillator is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiac Resynchronization Therapy Defibrillator. This report studies the global market size of Cardiac Resynchronization Therapy Defibrillator, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Cardiac Resynchronization Therapy Defibrillator production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019. In global market, the following companies are covered: Boston Scientific Medtronic St. Jude Medical Biotronik Spectranetics ... Market Segment by Product Type G158 G156 Others Market Segment by Application Hospital Clinic Others Key Regions split in this report: breakdown data for each region. United States China European Union Rest of World (Japan, Korea, India and Southeast Asia) The study objectives are: To analyze and research the Cardiac Resynchronization Therapy Defibrillator status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast. To present the key Cardiac Resynchronization Therapy Defibrillator manufacturers, presenting the sales, revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market In this study, the years considered to estimate the market size of Cardiac Resynchronization Therapy Defibrillator are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025
Table of Contents 1 Report Overview 1.1 Research Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Cardiac Resynchronization Therapy Defibrillator Market Size Growth Rate by Type (2019-2025) 1.3.2 G158 1.3.3 G156 1.3.4 Others 1.4 Market Segment by Application 1.4.1 Global Cardiac Resynchr
